Trace elements (TE) in broncho-alveolar lavage fluid (BALF) and corresponding serum (SE) of patients with inflammatory and neoplastic lung disease

W. Domej, J. Pavek, D. Kirsten, Z. Földes-Papp, G. P. Tilz, U. Demel (Graz, Austria; Hamburg, Germany)

Source: Annual Congress 2002 - Thoracic oncology: rare tumours and metastases
Session: Thoracic oncology: rare tumours and metastases
Session type: Thematic Poster Session
Number: 2939
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Domej, J. Pavek, D. Kirsten, Z. Földes-Papp, G. P. Tilz, U. Demel (Graz, Austria; Hamburg, Germany). Trace elements (TE) in broncho-alveolar lavage fluid (BALF) and corresponding serum (SE) of patients with inflammatory and neoplastic lung disease. Eur Respir J 2002; 20: Suppl. 38, 2939

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Bronchoalveolar lavage fluid (BALF) phospholipids (PL) and tumor necrosis factor-α (TNF-α) produced by alveolar macrophages (AM) can be used for predicting the course of sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 468s
Year: 2002

A comparison of T lymphocytes (TLs) subpopulations in lung tissue and in bronchoalveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2004; 24: Suppl. 48, 43s
Year: 2004

Correlation between cellularity of bronchoalveolar lavage (BAL) and parameters of lung function (LF) in patients with sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 180s
Year: 2003

Fibrocytes are detected in bronchoalveolar lavage (BAL) fluid in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003

Mechanisms of impaired immune surveillance in lower airways of smokers. Data from bronchoalveolar lavage (BAL) harvested in selected interstitial lung diseases (ILDs) and control group
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


Net inflammatory activity of bronchoalveolar lavage fluid (BALF) from patients following lung transplantation
Source: Eur Respir J 2002; 20: Suppl. 38, 348s
Year: 2002

Relationship of viral load in nasal lavage (NL), induced sputum (IS) and bronchoalveolar lavage (BAL) to symptom scores and lung function following experimental rhinovirus (RV) infection in asthmatic and normal human volunteers
Source: Annual Congress 2004 - Mechanisms and treatment of virus induced asthma exacerbations
Year: 2004


Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease
Source: Eur Respir J 2007; 30: Suppl. 51, 121s
Year: 2007

Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis-usual interstitial pneumonia (IPF-UIP) using SELDI-mass spectrometry
Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Year: 2007


Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005


CCR5 expression and CC-chemokine levels in broncho-alveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2002; 20: Suppl. 38, 598s
Year: 2002

Comparison between exhaled and bronchoalveolar lavage (BAL) levels of hydrogen peroxide (H2O2) in patients with diffuse interstitial lung diseases (DILD)
Source: Eur Respir J 2006; 28: Suppl. 50, 828s
Year: 2006

Levels of alkaline phosphatase (ALP), albumin (ALB) and D dimer (DD) in bronchoalveolar lavage (BAL) in patients with Interstitial lung disease (ILD)
Source: Eur Respir J 2002; 20: Suppl. 38, 468s
Year: 2002

Bronchoalveolar lavage fluid (BALF) findings in patients with immune checkpoint inhibitor (ICI)-associated interstitial pneumonia (IP)
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021



Is there any correlation between apoptosis of the cells from bronchoalveolar lavage fluid (BALF) and the progression of chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011

Alveolar lymphocytes (AL) produce interleukin 27 (IL27), antigen presenting cell-secreted cytokine. Increased expression of IL27 in bronchoalveolar lavage (BAL) of pulmonary sarcoidosis (PS) patients
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Broncholaveolar lavage (BAL) lymphocytes from patients with interstitial lung diseases (ILD) produce hepatocyte growth factor (HGF)
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009

Influence of systemic steroid treatment on bronchoalveolar (BAL) cytological composition and cell cycle in selected interstitial lung diseases
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013